Bristol-Myers Squibb sell Morgan Stanley
Start price
12.12.25
/
50%
€44.58
Target price
12.12.26
-
Performance (%)
28.71%
Price
11:19
€57.38
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 28.71%. This prediction currently runs until 12.12.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 3.575% | 3.575% |
| iShares Core DAX® | -0.874% | 5.325% |
| iShares Nasdaq 100 | -0.381% | 1.979% |
| iShares Nikkei 225® | -1.676% | 1.952% |
| iShares S&P 500 | -0.655% | 2.069% |
Comments by Morgan_Stanley for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Morgan_Stanley for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.13
10.07.25
10.07.25
€28.95
10.07.26
10.07.26
21.95%
11.07.26
11.07.26
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€56.01
12.11.24
12.11.24
€36.70
12.11.25
12.11.25
-23.83%
13.11.25
13.11.25
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.80
27.10.23
27.10.23
€47.31
27.10.24
27.10.24
-3.66%
28.10.24
28.10.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
11.10.23
11.10.23
€52.70
11.10.24
11.10.24
-11.04%
12.10.24
12.10.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.70
19.07.23
19.07.23
€52.70
19.07.24
19.07.24
-30.56%
20.07.24
20.07.24